Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ 12,968	$ 17,432
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Stock-based compensation	7,452	16,646
Depreciation and amortization	13,088	14,118
Changes in value of life insurance policies	6,407	(1,686)
Deferred income taxes	(1,807)	3,058
Gain on sale of business	0	(1,012)
Other non-cash items	31	(2,241)
Changes in assets and liabilities:
Accounts receivable	(3,390)	(12,135)
Inventories	(9,188)	(3,599)
Prepaid expenses and other current assets	2,347	2,443
Other assets	(851)	106
Accounts payable	4,288	9,661
Accrued expenses	(5,165)	(10,824)
Unearned revenues	(2,005)	1,410
Other liabilities	(12,430)	(3,952)
Net cash provided by operating activities	11,745	29,425
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(8,195)	(8,789)
Patents and other intangibles	(27)	(249)
Proceeds from sale of assets	426	487
Proceeds from sale of business, net of cash sold	240	513
Proceeds from insurance recovery	583	0
Net proceeds on life insurance policies	2,059	1,509
Net cash used in investing activities	(4,914)	(6,529)
CASH FLOWS FROM FINANCING ACTIVITIES:
Repayment of long-term debt	(49,000)	(194,000)
Proceeds from long-term debt	44,000	123,000
Debt issuance costs	(1,690)	0
Proceeds from issuance of common shares	0	60,000
Transaction costs on equity distribution program	(411)	(861)
Dividends paid	(1,389)	(1,372)
Repurchase of common shares	(2,311)	(3,911)
Other financing activities	(1)	(508)
Net cash used in financing activities	(10,802)	(17,652)
NET CHANGE IN CASH AND CASH EQUIVALENTS	(3,971)	5,244
CASH AND CASH EQUIVALENTS, beginning of period	17,703	13,806
CASH AND CASH EQUIVALENTS, end of period	13,732	19,050
Supplemental disclosures of cash flow information:
Cash payments for interest	7,101	8,841
Cash payments for income taxes	$ 10,475	$ 7,270